Venture Kick Stage II

We are excited to announce that aiEndoscopic has advanced to Venture Kick Stage 2, a crucial milestone on our path to entrepreneurial success. Venture Kick, a philanthropic three-stage funding model, has played a pivotal role, providing the resources to propel our academic project into a dynamic scaling venture. With unwavering support from Venture Kick, we have gained invaluable insights, transforming our vision into reality.

Venture Kick aims to empower Swiss startups by offering financial backing, mentorship, and networking opportunities. We are grateful for Venture Kick's instrumental role in our entrepreneurial journey. The funding, mentorship, and networking opportunities have accelerated our progress and provided a better understanding of the startup ecosystem.

Being selected for Venture Kick Stage 2 showcases the transformative potential of our project. With access to experienced mentors and industry experts, we have refined our strategies, strengthened our business model, and unlocked new growth opportunities.

The recognition and support from Venture Kick Stage 2 propel us forward in our mission to revolutionize healthcare through AI and robotic endoscopy. With a network of industry experts and investors, we are poised to scale our operations, drive innovation, and accelerate our market presence.

"Venture Kick has been instrumental in our entrepreneurial journey, providing us with the platform and resources to transform our academic project into a scaling venture," shared Philippe Ganz, CEO and Co-founder of aiEndoscopic. "The funding, mentorship, and networking opportunities offered by Venture Kick have allowed us to gain a better understanding of the startup ecosystem and accelerate our progress. We are grateful for their unwavering support in helping us bring our vision to life."

We extend our gratitude to Venture Kick for their belief in our vision and commitment to fostering entrepreneurial success. Their guidance, funding, and resources have been invaluable in shaping our growth trajectory. We are excited for the opportunities ahead as we continue to disrupt healthcare, improve patient outcomes, and transform lives.